Quantitative Determination of Free and Protein-Associated 3-Nitrotyrosine and S-Nitrosothiols in the Circulation by Mass Spectrometry and Other Methodologies: A Critical Review and Discussion from the Analytical and Review Point of View

Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases

Volumn , Issue , 2006, Pages 287-341

  Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Circulating 3 nitrotyrosine and S nitrosothiols quantitative analyses; Methods of analysis and method validation; Nitration and nitrosylation of L tyrosine and L cysteine

Indexed keywords

EID: 84889456088     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471973122.ch11     Document Type: Chapter

References (179)

1. Alpert C., Ramdev N., George D., Loscalzo J. (1997). Detection of S-nitrosothiols and other nitric oxide derivatives by photolysis-chemiluminescence spectrometry. Anal Biochem 245: 1-7.
2. Al-Sa'doni H., Ferro A. (2000). S-Nitrosothiols: a class of nitric oxide-donor drugs. Clin Sci 98: 507-520.
3. Andrew P.J., Mayer B. (1999). Enzymatic function of nitric oxide synthases. Cardiovasc Res 43: 521-531.
4. Arkenau H.T., Stichtenoth D.O., Frölich J.C., Manns M.P., Böker K.H.W. (2002). Elevated nitric oxide levels in patients with chronic liver diseases and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol 40: 907-912.
5. - donation by S-nitrosothiols: Implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318: 279-285.
6. Balazy M.J., Kaminski P.M., Mao K., Tan J., Wolin M.S. (1998). S-Nitroglutathione, a product of the reaction between peroxynitrite and glutathione that generates nitric oxide. J Biol Chem 273: 32009-32015.
7. Bland J.M., Altman D.G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
8. Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., Vadseth C., Narine L., Lenkiewicz E., Borchers M.T., Lusis A.J., Lee J.J., Lee N.A., Abu-Soud H.M., Ischiropoulos H., Hazen S.L. (2002). A tale of two controversies: defining both the role peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidasedeficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 277: 17415-17427.
9. Bryan N.S., Rassaf T., Rodriguez J., Feelisch M. (2004). Bound NO in human blood red cells: Fact or artifact? Nitric Oxide 10: 221-228.
10. Butler A.R., Rhodes P. (1997). Chemistry, analysis, and biological roles of S-nitrosothiols. Anal Biochem 249: 1-9.
11. Büttner J., Borth R., Boutwell J.H., Broughton P.M.G., Bowyer R.C. (1979). International Federation of Clinical Chemistry. Committee on Standards. Expert Panel on Nomenclature and Principles of Quality Control in Clinical Chemistry. Approved recommendation (1978) on quality control in clinical chemistry. Part 1. General principles and terminology. Clin Chim Acta 98: 129F-143F.
12. Cameron D.R., Borrajo A.M.P., Bennett B.M., Thatcher G.R.J. (1995). Organic nitrates, thionitrates, peroxynitrites, and nitric oxide: A molecular orbital study of the RXNO2 ⇔ RXONO (X = O, S) rearrangement, a reaction of potential biological significance. Can J Chem 73: 1627-1638.
13. Cannon R.O. III, Schechter A.N., Panza J.A., Ognibene F.P., Pease-Fye M.E., Waclawiw M.A., Shelhamer J.M., Gladwin M.T. (2001). Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 108: 279-287.
14. Ceriello A., Mercuri F., Quagliaro L., Assaloni R., Motz E., Tonutti L., Taboga C. (2001). Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress. Diabetologia 44: 834-838.
15. Ckless K., Reynaert N.L., Taatjes D.J., Lounsbury K.M., van der Vliet A., Janssen-Heininger Y. (2004). In situ detection and visualization of S-nitrosylated proteins following chemical derivatization: Identification of RAN GTPase as a target for S-nitrosylation. Nitric Oxide 11: 216-227.
16. Crowley J.R., Yarasheski K., Leeuwenburgh C., Turk J., Heinecke J.W. (1998). Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal Biochem 259: 127-135.
17. Daiber A., Bachschmid M., Kavakli C., Frein D., Wendt M., Ullrich V., Munzel T. (2004). A new pitfall in detecting biological end products of nitric oxide-Nitration, nitros(yl)ation and nitrite/nitrate artefact during freezing. Nitric Oxide 9: 44-52.
18. Damiani P., Burini G. (1986). Fluorometric determination of nitrite. Talanta 33: 649-652.
19. Dejam A., Kleinbongard P., Rassaf T., Hamada S., Gharini P., Rodriguez J., Feelisch M., Kelm M. (2003). Thiols enhance NO formation from nitrate photolysis. Free Radic Biol Med 35: 1551-1559.
20. L-tyrosine in biological fluids and tissues by isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry. Chem Res Toxicol 15: 1209-1217.
21. Delatour T., Guy P.A., Stadler R.H., Turesky R.J. (2002b). 3-Nitrotyrosine butyl ester: A novel derivative to assess tyrosine nitration in rat plasma by liquid chromatographytandem mass spectrometry detection. Anal Biochem 302: 10-18.
22. Denicola A., Freemann B.A., Trujillo M., Radi R. (1996). Peroxynitrite reaction with carbon dioxide/bicarbonate: Kinetics and influence on peroxynitrite-mediated oxidations. Arch Biochem Biophys 333: 49-58.
23. Du M., Wu W., Ercal N., Ma Y. (2004). Simultaneous determination of 3-nitro tyrosine, o-, m-. and p-tyrosine in urine samples by liquid chromatography-ultraviolet absorbance detection with pre-column cloud point extraction. J Chromatogr B 803: 321-329.
24. Ducrocq C., Blanchard B., Pignatelli B., Ohshima H. (1999). Peroxynitrite: An endogenous oxidizing and nitrating agent. Cell Mol Life Sci 55: 1068-1077.
25. Duncan M.W. (2003). A review of approaches to the analysis of 3-nitrotyrosine. Amino Acids 25: 351-361.
26. Dybkaer R. (1998). Terminological problems around "accuracy" and "uncertainty." Scand J Clin Lab Invest 58: 35-46.
27. Ellis G., Adatia I., Yazdanpanah M., Makela S.K. (1998). Nitrite and nitrate analyses: A clinical biochemistry perspective. Clin Biochem 31: 195-220.
28. Fahlbusch S.A., Tsikas D., Mehl C., Gutzki F.M., Böger R.H., Frölich J.C., Stichtenoth D.O. (2004). Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers. Eur J Clin Pharmacol 60: 83-88.
29. Feelisch M., Rassaf T., Mnaimneh S., Singh N., Bryan N.S., Jourd'heuil D., Kelm M. (2002). Concomitant S-, N-and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J 16: 1775-1785.
30. Ferdinandy P., Danial H., Ambrus I., Rothery R.A., Schulz R. (2000). Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87: 241-247.
31. Ferranti P., Malorni A., Mamone G., Sannolo N., Marino G. (1997). Characterisation of S-nitrosohaemoglobin by mass spectrometry. FEBS Lett 400: 19-24.
32. Ford P.C., Wink D.A., Standbury D.M. (1993). Autoxidation kinetics of aqueous nitric oxide. FEBS Lett 326: 1-3.
33. Förstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath I., Kleinert H. (1994). Nitric oxide synthase isozymes: Characterization, purification, molecular cloning, and functions. Hypertension 23: 1121-1131.
34. Frehm E.J., Bonaventura J., Gow A.J. (2004). S-Nitrosohaemoglobin: an allosteric mediator of NO group function in mammalian vasculature. Free Radic Biol Med 37: 442-453.
35. Frost M.T., Halliwell B., Moore K.P. (2000). Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J 345: 453-458.
36. Gandley R.E., Tyurin V.A., Huang W., Arroyo A., Daftary A., Harger G., Jiang J., Pitt B., Taylor R.N., Hubel C.A., Kagan V.E. (2005). S-Nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: Effects in pregnancy and preeclampsia plasma. Hypertension 45: 1-7.
37. Gaston B. (1999). Nitric oxide and thiol groups. Biochim Biophys Acta 1411: 323-333.
38. Gaut J.P., Byun J., Tran H.D., Heinecke J.W. (2002). Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Biochem 300: 252-259.
39. Giustarini D., Milzani A., Colombo R., Dalle-Donne I., Rossi R. (2003). Nitric oxide and S-nitrosothiols in human blood. Clin Chim Acta 330: 85-98.
40. Giustarini D., Milzani A., Colombo R., Dalle-Donne I., Rossi R. (2004). Nitric oxide, Snitrosothiols and haemoglobin: Is methodology the key? TRENDS Pharmacol Sci 25: 311-316.
41. Giustarini D., Rossi R. (2004). Plasma S-nitrosothiols and chronic renal failure. Am J Physiol Renal Physiol 287: F1294-F1295.
42. Gladwin M.T., Shelhamer J.H., Schechter A.N., Pease-Fye M.E., Waclawiw M.A., Panza J.A., Ognibene F.P., Cannon R.O. III (2000). Role of circulating nitrite and S-nitrosohaemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci USA 97: 11482-11487.
43. Gladwin M.T., Crawford J.H., Patel R.P. (2004). The biochemistry of nitric oxide, nitrite, and haemoglobin: Role in blood flow regulation. Free Radic Biol Med 36: 707-714.
44. 2: evidence for radical formation in a solvent cage. J Am Chem Soc 121: 2444-2447.
45. Gow A., Duran D., Thom S.R., Ischiropoulos H. (1996). Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys 333: 42-48.
46. Gow A.J., Stamler J.S. (1998). Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 391: 169-173.
47. Haendeler J., Hoffmann J., Zeiher A.M., Dimmeler S. (2004). Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: A novel vasculoprotective function of statins. Circulation 110: 856-861.
48. Halliwell B. (1997). What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411: 155-160.
49. Halliwell B., Gutteridge J.M.C. (1999). Free Radicals in Biology and Medicine, 3rd ed., Oxford University Press, Oxford.
50. Halliwell B., Zhao K., Whiteman M. (1999). Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good. Free Rad Res 31: 651-669.
51. Hensley K., Williamson K.S., Floyd R.A. (2000). Measurement of 3-nitrotyrosine and 5-nitro-γ-tocopherol by high-performance liquid chromatography with electrochemical detection. Free Radic Biol Med 28: 520-528.
52. Herce-Pagliai C., Kotecha S., Shuker D.E.G. (1998). Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. Nitric Oxide 2: 324-336.
53. Hibbs J.B. Jr, Taintor R.R., Vavrin Z. (1987). Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476.
54. Hill R.E., Whelan D.T. (1984). Mass spectrometry and clinical chemistry. Clin Chim Acta 139: 231-294.
55. Hobbs A.J., Fukuto J.M., Ignarro L.J. (1994). Formation of free nitric oxide from Larginine by nitric oxide synthase: Direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci USA 91: 10992-10996.
56. Huie R.E., Padmaja S. (1993). The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199.
57. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. (1987). Endotheliumderived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269.
58. Ischiropoulos H. (1998). Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356: 1-11.
59. Iyengar R., Stuehr D.J., Marletta M.A. (1987). Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: Precursors and role of the respiratory burst. Proc Natl Acad Sci USA 84: 6369-6373.
60. Jaffrey S.R., Snyder S.H. (2001). The biotin switch method for the detection of Snitrosylated proteins. Sci STKE: L1.
61. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., Snyder S.H. (2001). Proteins S-nitrosylation: A physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-197.
62. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. (1996). S-Nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 380: 221-226.
63. Jiang H., Balazy M. (1998). Detection of 3-nitrotyrosine in human platelets exposed to peroxynitrite by a new gas chromatography/mass spectrometry assay. Nitric Oxide 2: 350-359.
64. Jourd'heuil D., Miranda K.M., Kim S.M., Espey M.G., Vodovotz Y., Laroux S., Mai C.T., Miles A.M., Grisham M.B., Wink D.A. (1999). The oxidative and nitrosative chemistry of the nitric oxide/superoxide reaction in the presence of bicarbonate. Arch Biochem Biophys 365: 92-100.
65. Jourd'heuil D., Hallén K., Feelisch M., Grisham M.B. (2000). Dynamic state of Snitrosothiols in human plasma and whole blood. Free Radic Biol Med 28: 409-417.
66. Kamisaki Y., Wada K., Nakamoto K., Kishimoto Y., Kitano M., Itoh T. (1996). Sensitive determination of nitrotyrosine in human plasma by isocratic high-performance liquid chromatography. J Chromatogr B 685: 343-347.
67. Keimer R., Stutzer F.K., Tsikas D., Troost R., Gutzki F.M., Frölich J.C. (2003). Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: a randomized, double-blind crossover study. J Cardiovasc Pharmacol 41: 284-292.
68. Khan J., Brennan D.M., Bradley N., Gao B., Bruckdorfer R., Jacobs M. (1998). 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J 330: 795-801.
69. Kissner R., Koppenol W. (2002). Product distribution of peroxynitrite decay as a function of pH, temperature, and concentration. J Am Chem Soc 124: 234-239.
70. Kluge I., Gutteck-Amsler U., Zollinger M., Do K.Q. (1997). S-Nitrosoglutathione in rat cerebellum: Identification and quantification by liquid chromatography-mass spectrometry. J Neurochem 69: 2599-2607.
71. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., Nagano T. (1998). Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70: 2446-2453.
72. Kuncewicz T., Sheta E.A., Goldknopf I.L., Kone B.C. (2003). Proteomic analysis of Snitrosylated proteins in messangial cells. Mol Cell Proteomics 2: 156-163.
73. Lawson A.M., Gaskell S.J., Hjelm M. (1985). Methodological aspects on quantitative mass spectrometry used for accuracy control in clinical chemistry. J Clin Chem Clin Biochem 23: 433-441.
74. Lemercier J.N., Padmaja S., Cueto R., Squadrito G.L., Uppu R.M., Pryor W.A. (1997). Carbon dioxide modulation of hydroxylation and nitration of phenol by peroxynitrite. Arch Biochem Biophys 345: 160-170.
75. L-tyrosine. J Chromatogr B 713: 289-295.
76. 2-Catalyzed one-electron oxidations by peroxynitrite: properties of the reactive intermediated. Inorg Chem 37: 294-301.
77. Mansoor M.A., Svardal A.M., Ueland P.M. (1992). Determination of the in vivo redox status of cysteine, cysteinylglycine, homocystine, and glutathione in human plasma. Anal Biochem 200: 218-229.
78. Marletta M.A. (1993). Nitric oxide synthase structure and mechanism. J Biol Chem 268: 12231-12234.
79. Marzinzig M., Nussler A.K., Stadler J., Marzinzig E., Barthlen W., Nussler N.C., Berger H.G., Morris S.M., Brückner U.B. (1997). Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1: 177-189.
80. Massy Z.A., Borederie D., Nguyen T., Drüeke T.B., Ekindjian O.G., Lacour B. (2003). Increased plasma S-nitrosothiol levels in chronic haemodialysis patients. Nephrol Dial Transplant 18: 153-157.
81. Massy Z.A., Fumeron C., Borederie D., Tuppin P., Nguyen-Khoa T., Benoit M.O., Jacquot C., Buisson C., Drüeke T.B., Ekindjian O.G., Lacour B., Iliou M.C. (2004). Increased plasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: A prospective study. J Am Soc Nephrol 15: 470-476.
82. Masumoto H., Kissner R., Koppenol W.H., Sies H. (1996). Kinetic study of the reaction of ebselen with peroxynitrite. FEBS Lett 398: 179-182.
83. Mayer B., Pfeiffer S., Schrammel A., Koesling D., Schmidt K., Brunner F. (1998). A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem 273: 3264-3270.
84. Meyer D.J., Kramer H., Özer N., Coles B., Ketterer B. (1994). Kinetics and equilibria of S-nitrosothiol-thiol exchange between glutathione, cysteine, penicillamines and serum albumin. FEBS Lett 345: 177-180.
85. Mirza U.A., Chait B.T., Lander H.M. (1995). Monitoring reactions of nitric oxide with peptides and proteins by electrospray ionization-mass spectrometry. J Biol Chem 270: 17185-17188.
86. Moriel P., Pereira I.R.O., Bertolami M.C., Abdalla S.P. (2001). Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia? Free Radic Biol Med 30: 318-326.
87. Myers P.R., Minor R.L. Jr, Guerra R. Jr, Bates J.N., Harrison D.G. (1990). Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163.
88. Nedospasov A., Rafikov R., Beda N., Nudler E. (2000). An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci USA 97: 13543-13548.
89. Ng E.S.M., Jourd'heuil D., McCord J.M., Hernandez D., Yasui M., Knight D., Kubes P. (2004). Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 94: 559-565.
90. Noyes W.A. (1943). n-Butyl nitrite. Org Syn Coll 2: 108-109.
91. Ohshima H., Friesen M., Brouet I., Bartsch H. (1990). Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxic 28: 647-652.
92. Oldreive C., Bradley N., Bruckdorfer R., Rice-Evans C. (2001). Lack of influence of dietary nitrate/nitrite on plasma nitrotyrosine levels measured using a competitive inhibition of binding ELISA assay. Free Rad Res 35: 377-386.
93. Palmer R.M.J., Ashton D.S., Moncada S. (1988a). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
94. Palmer R.M.J., Rees D.D., Ashton D.S., Moncada S. (1988b). L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153: 1251-1256.
95. Peters T. Jr (1985). Serum albumin. Adv Prot Chem 37: 161-245.
96. Petersson A.S., Steen H., Kalume D.E., Caidahl K., Roepstorff P. (2001). Investigation of tyrosine nitration in proteins by mass spectrometry. J Mass Spectrom 36: 616-625.
97. Petruzzelli S., Puntoni R., Mimotti P., Pulera N., Baliva F., Fornai E., Giuntini C. (1997). Plasma 3-nitrotyrosine in cigarette smokers. Am J Respir Crit Care Med 156: 1902-1907.
98. Pfeiffer S., Gorren A.C.F., Schmidt K., Werner E.R., Hansert B., Bole D.S., Mayer B. (1997). Metabolic fate of peroxynitrite in aqueous solution: Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. J Biol Chem 272: 3465-3470.
99. Pfeiffer S., Mayer B. (1998). Lack of tyrosine nitration by peroxynitrite generated at physiological pH. J Biol Chem 273: 27280-27285.
100. Pignatelli B., Li C.Q., Boffetta P., Chen Q., Ahrens W., Nyberg F., Mukeria A., Bruske-Hohlfeld I., Fortes C., Constantinescu V., Ischiropoulos H., Ohshima H. (2001). Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res 61: 778-784.
101. Pogrebnaya V.L., Usov A.P., Baranov A.V., Nesterenko A.I., Bez'yazychnyi P.I. (1975). Oxidation of nitric oxide by oxygen in the liquid phase. J Appl Chem USSR 48: 1004-1007.
102. Porter A.M.W. (1999). Misuse of correlation and regression in three medical journals. J Royal Soc Med 92: 123-128.
103. Pou S., Pou W.S., Bredt D.S., Snyder S.H., Rosen G.M. (1992). Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267: 24173-24176.
104. Radák Z., Ogonovszky H., Dubecz J., Sasvari M., Pucsok J., Berkes I., Csont T., Ferdinandy P. (2003). Super-marathon race increases serum and urinary nitrotyrosine and carbonyl levels. Eur J Clin Pharmacol 33: 726-730.
105. Radi R., Peluffo G., Alvarez M.N., Naviliat M., Cayota A. (2001). Unravelling peroxynitrite formation in biological systems. Free Radic Biol Med 30: 463-488.
106. Rafikova O., Rafikov R., Nudler E. (2002). Catalysis of S-nitrosothiols formation by serum albumin: The mechanism and implication in vascular control. Proc Natl Acad Sci USA 99: 5913-5918.
107. Richardson G., Benjamin N. (2002). Potential therapeutic uses for S-nitrosothiols. Clin Sci 102: 99-105.
108. Rossi R., Giustarini D., Milzani A., Colombo R., Dalle-Donne I., Di Simplicio P. (2001). Physiological levels of S-nitrosothiols in human plasma. Circ Res 89: e47.
109. Sarver A., Scheffler N.K., Shetlar M.D., Gibson B.W. (2001). Analysis of peptides and proteins containing nitrotyrosine by matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 12: 439-448.
110. Saville B. (1958). A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83: 670-672.
111. Scharfstein J.S., Keaney J.F. Jr, Slivka A., Welch G.N., Vita J.A., Stamler J.S. (1994). In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest 94: 1432-1439.
112. Schechter A.N., Gladwin M.T. (2003). Haemoglobin and the paracrine functions of nitric oxide. N Engl J Med 348: 1483-1485.
113. Schmidt H.H.H.W., Nau H., Wittfoht W., Gerlach J., Prescher K.E., Klein M.M., Niroomand F., Böhme E. (1988). Arginine is a physiological precursor of endotheliumderived nitric oxide. Eur J Pharmacol 154: 213-216.
114. Schmidt H.H.H.W., Hofmann H., Schindler U., Shutenko Z.S., Cunningham D.D., Feelisch M. (1996). No NO from NO synthase. Proc Natl Acad Sci USA 93: 14492-14497.
115. Schoeller D.A. (1986). Mass spectrometry: calculations. J Clin Pharmacol 26: 396-399.
116. L-tyrosine by gas chromatography-mass spectrometry. J Labelled Cpds Radiopharm 41: 773-780.
117. Schwedhelm E., Tsikas D., Gutzki F.M., Frölich J.C. (1999). Gas chromatographic-tandem mass spectrometric quantification of free 3-nitrotyrosine in human plasma at the basal state. Anal Biochem 276: 195-203.
118. Schwemmer M., Fink B., Köckerbauer R., Bassenge E. (2000). How urine analysis reflects oxidative stress-Nitrotyrosine as a potential marker. Clin Chim Acta 297: 207-216.
119. Shaffer J.E., Han B.J., Chern W.H., Lee F.W. (1992). Lack of tolerance to a 24-hour infusion of S-nitroso-N-acetylpenicillamine (SNAP) in conscious rabbits. J Pharmacol Exp Ther 260: 286-293.
120. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittmann K.A., Spector S. (1992). Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. J Pharmaceut Sci 81: 309-312.
121. Shigenaga M.K., Lee H.H., Blount B.C., Christen S., Shigeno E.T., Yip H., Ames B.N. (1997). Inflammation and NOx-induced nitration: assay for 3-nitrotyrosine by HPLC with electrochemical detection. Proc Natl Acad Sci USA 94: 3211-3216.
122. Shigenaga M.K. (1999). Quantitation of protein-bound 3-nitrotyrosine by highperformance liquid chromatography with electrochemical detection. Methods Enzymol 301: 27-40.
123. Shishehbor M.H., Aviles R.J., Brennan M.L., Fu X., Goormastic M., Pearce G.L., Gokce N., Keaney J.F. Jr, Penn M.S., Sprecher D.L., Vita J.A., Hazen S.L. (2003a). Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289: 1675-1680.
124. Shishehbor M.H., Brennan M.L., Aviles R.J., Fu X., Penn M.S., Sprecher D.L., Hazen S.L. (2003b). Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 108: 426-431.
125. Skinner K.A., Whites C.R., Patel R., Tan S., Barnes S., Kirk M., Darley-Usmar V., Parks D.A. (1998). Nitrosation of uric acid by peroxynitrite: Formation of a vasoactive nitric oxide donor. J Biol Chem 273: 24491-24497.
126. Smith C.C.T., Stanyer L., Betteridge D.J. (2002). Evaluation of methods for the extraction of nitrite and nitrate in biological fluids employing high-performance anion-exchange liquid chromatography for their determination. J Chromatogr B 779: 201-209.
127. Söderling A.S., Ryberg H., Gabrielson A., Lärstad M., Torén K., Niari S., Caidahl K. (2003). A derivatization assay using gaschromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma. J Mass Spectrom 38: 1187-1196.
128. Squadrito G.L., Jin X., Pryor W.A. (1995). Stopped-flow kinetic study of the reaction of ascorbic acid with peroxynitrite. Arch Biochem Biophys 322: 53-59.
129. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., Singel D., Valeri C.R., Loscalzo J. (1992a). Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89: 7674-7677.
130. Stamler J.S., Simon D.I., Osborne J., Mullins M.E., Jaraki O., Michel T., Singel D.J., Loscalzo J. (1992b). S-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biological active compounds. Proc Natl Acad Sci USA 89: 444-448.
131. Stamler J. (2004). S-Nitrosothiols in the blood: Roles, amounts, and methods of analysis. Circ Res 94: 414-417.
132. Strand Ø.A., Leone A., Giercksky K.E., Kirkebøen K.A. (2000). Nitric oxide indices in human septic shock. Crit Care Med 28: 2779-2785.
133. Svatikova A., Wolk R., Wang H.H., Otto M.E., Bybee K.A., Singh R.J., Somers V.K. (2004). Circulating free nitrotyrosine in obstructive sleep apnea. Am J Physiol Regul Comp Physiol 287: R284-R287.
134. Szilvássi Z., Csont T., Páli T., Droy-Lefaix M.T., Ferdinandy P. (2001). Nitric oxide, peroxynitrite and cGPM in atherosclerosis-induced hypertension in rabbits: Beneficial effects of cicletanine. J Vasc Res 38: 39-46.
135. Tashimo O., Ishibashi T., Yoshida J., Tsuchida H., Nishio M. (2003). Interference with Saville's method in the determination of low-molecular weight S-nitrosothiols by ultrafiltration. Nitric Oxide 9: 148-152.
136. ter Steege J.C.A., Koster-Kamphuis L., van Straaten E.A., Forget P.P., Buurman W.A. (1998). Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med 25: 953-963.
137. Thompson M., Ellison S.L.R., Wood R. (2002). Harmonized guidelines for singlelaboratory validation of methods of analysis. Pure Appl Chem 74: 835-855.
138. Troost R., Schwedhelm E., Rojczyk S., Tsikas D., Frölich J.C. (2000). Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol 50: 377-379.
139. 15N-labelled analogs. J Chromatogr B 661: 185-191.
140. Tsikas D., Rossa S., Stichtenoth D.O., Raida M., Gutzki F.M., Frölich J.C. (1996). Is Snitroso-N-acetyl-L-cysteine a circulating or an excretory metabolite of nitric oxide (NO) in man? Assessment by gas chromatography-mass spectrometry. Biochem Biophys Res Commun 220: 939-944.
141. Tsikas D., Sandmann J., Rossa S., Gutzki F.M., Frölich J.C. (1999a). Investigations of S-transnitrosylation reactions between low-and high-molecular-weight S-nitroso compounds and their thiols by high-performance liquid chromatography and gas chromatography-mass spectrometry. Anal Biochem 270: 231-241.
142. 15N]nitrosoalbumin in human blood in vitro. J Chromatogr B 726: 1-12.
143. Tsikas D., Sandmann J., Holzberg D., Pantazis P., Raida M., Frölich J.C. (1999c). Determination of S-nitrosoglutathione in human and rat plasma by high-performance liquid chromatography with fluorescence and ultraviolet absorbance detection after precolumn derivatization with o-phthaldehyde. Anal Biochem 273: 32-40.
144. 15N]nitrosoalbumin as internal standard. J Chromatogr B 726: 13-24.
145. Tsikas D., Sandmann J., Rossa S., Gutzki F.M., Frölich J.C. (1999e). Gas chromatographic-mass spectrometric detection of S-nitroso-cysteine and S-nitroso-glutathione. Anal Biochem 272: 117-122.
146. Tsikas D., Gutzki F.M., Sandmann J., Schwedhelm E., Frölich J.C. (1999f). Quantification of plasma and urinary nitrate after its reduction to nitrite and to the pentafluorobenzyl derivative by gas chromatography-tandem mass spectrometry. J Chromatogr B 731: 285-301.
147. Tsikas D., Sandmann J., Denker K., Frölich J.C. (2000a). Is S-nitrosoglutathione formed in nitric oxide synthase incubates? FEBS Lett 483: 83-85.
148. Tsikas D., Raida M., Sandmann J., Rossa S., Forssmann W.G., Frölich J.C. (2000b). Electrospray ionization mass spectrometry of low-molecular-mass S-nitroso compounds and their thiols. J Chromatogr B 742: 99-108.
149. Tsikas D., Sandmann J., Lueßen P., Savva A., Rossa S., Stichtenoth D.O., Frölich J.C. (2001a). S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat. Biochim Biophys Acta 1546: 422-434.
150. Tsikas D., Denker K., Frölich J.C. (2001b). Artifactual-free analysis of S-nitrosoglutathione and S-nitroglutathione by neutral-pH, anion-pairing, high-performance liquid chromatography: Study on peroxynitrite-mediated S-nitration of glutathione to S-nitroglutathione under physiological conditions. J Chromatogr A 915: 107-116.
151. Tsikas D., Frölich J.C. (2002a). Is circulating nitrite a directly acting vasodilator? Clin Sci 103: 107-110.
152. Tsikas D., Frölich J.C. (2002b). S-Nitrosoalbumin plasma levels in healthy and disease: facts or artifacts? Value of analytical chemistry in nitric oxide clinical research. Circ Res 90: e39.
153. Tsikas D., Schwedhelm E., Frölich J.C. (2002a). Methodological considerations on the detection of 3-nitrotyrosine in the cardiovascular system. Circ Res 90: e70.
154. 2+ via intermediate formation of S-nitrosocysteine and nitric oxide. J Chromatogr B 772: 335-346.
155. Tsikas D. (2003). Measurement of physiological S-nitrosothiols: a problem child and a challenge. Nitric Oxide 9: 53-55.
156. Tsikas D., Schwedhelm E., Stutzer F.K., Gutzki F.M., Rode I., Mehls C., Frölich J.C. (2003a). Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry. J Chromatogr B 784: 77-90.
157. 2α in end-stage liver disease. Hepatology 38: 1063-1064.
158. Tsikas D., Frölich J.C. (2003). Are plasma S-nitrosothiol levels elevated in chronic renal failure? Nephrol Dial Transplant 918: 2199-2201.
159. Tsikas D. (2004). S-Nitrosoalbumin and other S-nitrosothiols in the blood. Is their quantity of no relevance? Circ Res 94: e106.
160. Tsikas D., Frölich J.C., Kielstein J.T. (2004). Nitric oxide synthesis in chronic renal failure: Are plasma S-nitrosothiol levels elevated? Clin Chim Acta 339: 195-197.
161. Tsikas D., Frölich J.C. (2004). Trouble with the analysis of nitrite, nitrate, S-nitrosothiols and 3-nitrotyrosine: freezing-induced artifacts? Nitric Oxide 11: 209-213.
162. Tsikas D. (2005a). Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 39: 797-815.
163. Tsikas D. (2005b). Analysis of the L-arginine/nitric oxide pathway: The unique role of mass spectrometry. Curr Pharmac Anal 1: 15-30.
164. Tsikas D., Caidahl K. (2005). Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma. J Chromatogr B 814: 1-9.
165. Tsikas D., Mitschke A., Suchy M.T., Gutzki F.M., Stichtenoth D.O. (2005). Determination of 3-nitrotyrosine in human urine at the basal state by gas chromatography-tandem mass spectrometry and evaluation of the excretion after oral intake. J Chromatogr B, 827: 146-156.
166. Tyurin V.A., Liu S.X., Tyurina Y.Y., Sussman N.B., Hubel C.A., Roberts J.M., Taylor R.N., Kagan V.E. (2001). Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res 88: 1210-1215.
167. Uppu R.M., Squadrito G.L., Pryor W.A. (1996). Acceleration of peroxynitrite oxidations by carbon dioxide. Arch Biochem Biophys 327: 335-343.
168. Vásquez-Vivar J., Kalyanaraman B., Martásek P., Hogg N., Masters B.S.S., Karoui H., Tordo H., Pritchard K.A. (1998). Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA 95: 9229-9225.
169. van der Vliet A., 't Hoen P.A.C., Wong P.S.Y., Bast A., Cross C.E. (1998). Formation of S-nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide. J Biol Chem 273: 30255-30262.
170. 15N NMR and electronic properties of S-nitrosothiols. Bioinorg Medic Chem Lett 9: 2897-2902.
171. Wang H.H., Lagerstedt S.A., Heinecke J.W., Singh R.J. (2003). LC-MS/MS quantification of circulating free nitrotyrosine. Evidence of elevated free nitrotyrosine in hypertensive patients. In: Proceedings of the 1st ASMS Conference on Mass Spectrometry Allied Topics TPC 050.
172. Wlodek P.J., Kucharczyk J., Sokolovska M.M.,Milkowski A., Markiewicz O.B., Smolenski O.B., Wlodek L.B. (2003). Alteration in plasma levels of nonproteins sulfhydryl compounds and S-nitrosothiols in chronic renal failure. Clin Chim Acta 327: 87-94.
173. Xia Y., Zweier J.L. (1997). Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94: 6954-6958.
174. Yang B.K., Vivas E.X., Reiter C.D., Gladwin M.T. (2003). Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Rad Res 37: 1-10.
175. Yi D., Ingelse B.A., Duncan M.W., Smythe G.A. (2000). Quantification of 3-nitrotyrosine in biological tissues and fluids: Generating valid results by eliminating artifactual formation. J Am Soc Mass Spectrom 11: 578-586.
176. Zhang H., Squadrito G.L., Uppu R.M., Lemercier J.N., Cueto R., Pryor W.A. (1997). Inhibition of peroxynitrite-mediated oxidation of glutathione by carbon dioxide. Arch Biochem Biophys 339: 183-189.
177. Zhang Y., Hogg N. (2005). S-Nitrosothiols: Cellular formation and transport. Free Radic Biol Med 38: 831-838.
178. Zhang Y., Keszler A., Broniowska K.A., Hogg N. (2005). Characterization and application of the biotin-switch assay for the identification of S-nitrosated proteins. Free Radic Biol Med 38: 874-881.
179. Zoccali C., Bode-Böger S.M., Mallamaci F., Benedetto F.A., Tripepi G., Malatino L.S., Catalioti A., Bellanuova I., Fermo I., Frölich J.C., Böger R.H. (2001). Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358: 2113-2117.